Ebola vaccine trial begins in DR Congo
Full story
A new trial for an Ebola vaccine has officially started in the Democratic Republic of Congo. Researchers are testing the effectiveness of the shot in a region prone to outbreaks. The study aims to provide a safer way to prevent the deadly virus. Local health authorities are coordinating the distribution of the vaccine to volunteers. This effort is part of a global strategy to stop the disease from spreading. Results from the trial will inform future vaccination campaigns. The goal is to create a long-term shield against the virus.